OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 29
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 29
Showing 26-50 of 29 citing articles:
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies"
Henu Kumar Verma, Poojarani Panda, L.V.K.S. Bhaskar
(2023)
Open Access | Times Cited: 1
Henu Kumar Verma, Poojarani Panda, L.V.K.S. Bhaskar
(2023)
Open Access | Times Cited: 1
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies
Poojarani Panda, Henu Kumar Verma, L.V.K.S. Bhaskar
Onco (2023) Vol. 3, Iss. 3, pp. 127-146
Open Access | Times Cited: 1
Poojarani Panda, Henu Kumar Verma, L.V.K.S. Bhaskar
Onco (2023) Vol. 3, Iss. 3, pp. 127-146
Open Access | Times Cited: 1
Identification of Key Genes and Pathways Governing T-DM1 Resistance in OE-19 Esophageal Cancer Cells through Bioinformatics Analysis
Fateme Yazdani, Negar Mottaghi-Dastjerdi, Abozar Ghorbani, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Fateme Yazdani, Negar Mottaghi-Dastjerdi, Abozar Ghorbani, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Cost-effectiveness of analysis serplulimab plus chemotherapy as first-line therapy for PD-L1-positive advanced esophageal squamous cell carcinoma
Hanrui Zheng, Jiafeng Li, Feng Wen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Hanrui Zheng, Jiafeng Li, Feng Wen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Personalized mRNA Vaccine Combined with PD-1 Inhibitor Therapy in a Patient with Advanced Esophageal Squamous Cell Carcinoma
Bin Wang, Xiaobo Peng, Jie Li, et al.
Research Square (Research Square) (2023)
Open Access
Bin Wang, Xiaobo Peng, Jie Li, et al.
Research Square (Research Square) (2023)
Open Access
